Biomarker Operations Lead – Clinical Trials & Strategy

Socket.dev; San Diego (CA); On-site; USD 150,000 - 165,000; Full time

Benefits offered by this job

Annual bonus

Equity

Generous benefits package

Job summary

Fate Therapeutics is seeking a Senior Manager, Biomarker Operations in San Diego to lead biomarker sample operations across clinical studies, working with Translational and Clinical teams to design robust biospecimen handling.

You will maintain sample inventories, oversee CROs and labs, manage budgets and audits, and drive SOP improvements while coordinating data reporting and study updates for our biomarker programs.

Qualifications

• MS or higher degree with 3+ years of experience in biomarker operations, or BS degree with 5+ years of relevant experience.
• Demonstrated experience managing clinical or biomarker operations from study initiation through completion, including collaboration with central labs and CROs to execute biomarker study plans.
• Experience with clinical trial sites and related clinical CROs; knowledge of cancer biology, immunology, biomarkers, drug development, and trial methodology is a plus.

Responsibilities

• Lead day-to-day biomarker sample operations for clinical studies, including sample logistics, issue resolution, protocol amendments, and lab manual updates.
• Partner with Translational and Clinical teams to design and implement biospecimen collection and handling approaches.
• Maintain accurate sample inventories and oversee storage solutions; manage data reporting from CROs into vendor systems.

Skills

Biomarker operations

Sample logistics

Cross-functional collaboration

Communication skills

Education

MS or higher in related field

Tools

LIMS

Job description

Fate Therapeutics is seeking a Senior Manager, Biomarker Operations in San Diego to lead biomarker sample operations across clinical studies, working with Translational and Clinical teams to design robust biospecimen handling.

You will maintain sample inventories, oversee CROs and labs, manage budgets and audits, and drive SOP improvements while coordinating data reporting and study updates for our biomarker programs.